Phaxiam Therapeutics S.a. sell Lokrim
Start price
04.03.24
/
20%
€2.80
Target price
04.03.25
-
Performance (%)
-38.57%
End price
17.08.24
€1.72
Summary
This prediction ended on 17.08.24 with a price of €1.72. The SELL prediction by Lokrim for Phaxiam Therapeutics S.a. performed very well with a performance of -38.57%. Lokrim has 20% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Phaxiam Therapeutics S.a. | - | - |
| iShares Core DAX® | 1.665% | 0.362% |
| iShares Nasdaq 100 | -0.475% | -3.195% |
| iShares Nikkei 225® | 2.620% | 1.174% |
| iShares S&P 500 | -0.091% | -1.597% |
According to Lokrim what are the pros and cons of Phaxiam Therapeutics S.a. for the foreseeable future?
Pros
Cons
Significant cyclical dependencies
Comments by Lokrim for this prediction
In the thread Phaxiam Therapeutics S.a. diskutieren
Sell Phaxiam Therapeutics S.a.